MedTrace Logo

AIO-BNHO Comprehensive Clinico-genomics Database Network - AIO-BNHO CONNECT

NCT05701150 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 3000

Last updated 2025-02-17

No results posted yet for this study

Summary

National, retro- and prospective, observational, multicenter clinical research platform to connect clinical and genomic data of patients with advanced (locally advanced, inoperable, or metastatic) solid tumors (excluding NSCLC, SCLC, and mesothelioma) with results from multi-gene next-generation sequencing (NGS) panels (\>30 genes)

Conditions

  • Advanced Solid Tumor

Interventions

OTHER

Minimal documentation

Minimal data documentation only of patients without targeted therapy based on NGS results

OTHER

Extended documentation

Extended data documentation of patients with targeted therapy based on NGS results

Sponsors & Collaborators

  • Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company

    collaborator INDUSTRY

  • Merck Sharp & Dohme LLC

    collaborator INDUSTRY

  • Janssen-Cilag G.m.b.H

    collaborator INDUSTRY

  • AIO-Studien-gGmbH

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-12-08
Primary Completion
2025-12-31
Completion
2025-12-31

Countries

  • Germany

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05701150 on ClinicalTrials.gov